9:22 AM
Leo Group India
| ||
| Jazz Pharmaceuticals Completes EUSA Pharma Acquisition Sacramento Bee By Jazz Pharmaceuticals plc DUBLIN, June 12, 2012 -- /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the closing of its acquisition of EUSA Pharma, a privately-held, specialty pharmaceutical company with a commercial presence in ... See all stories on this topic » | ||
| Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic ... MarketWatch (press release) AUSTIN, Texas, June 12, 2012 /PRNewswire via COMTEX/ -- Savara Pharmaceuticals, an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life-threatening conditions, today announced positive ... See all stories on this topic » | ||
| Savara Pharmaceuticals Adds $8.6M Private Equity Hub (press release) Austin-based specialty pharmaceutical company Savara Pharmaceuticals has raised $8.6 million in a first closing of its Series B round. The Keiretsu Forum led the round. Savara is a developer of pulmonary drugs. Savara Pharmaceuticals, an emerging ... See all stories on this topic » | ||
| Terry Yon Encourages Higher Standards of Pharmaceutical Care MarketWatch (press release) Terry Yon, Florida-based pharmacist, believes these professionals are qualified to handle such administration and that the overall benefits of increased pharmaceutical care would greatly improve American health care. TALLAHASSEE, Fla., June 12, ... See all stories on this topic » | ||
| Raptor Pharmaceutical Corp. to Present at the 2012 Wells Fargo Securities ... MarketWatch (press release) NOVATO, Calif., Jun 12, 2012 (GlobeNewswire via COMTEX) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (NASDAQ:RPTP) , today announced that Christopher M. Starr, Ph.D., Chief Executive Officer of Raptor, will present an overview of the ... See all stories on this topic » | ||
| Cornerstone Therapeutics Appoints Dr. Laura Shawver to Board of Directors MarketWatch (press release) CARY, NC, Jun 12, 2012 (MARKETWIRE via COMTEX) -- Cornerstone Therapeutics Inc. (NASDAQ:CRTX) , a specialty pharmaceutical company focused on commercializing products for the hospital, niche respiratory and related specialty markets, today announced ... See all stories on this topic » | ||
| ADVENTRX And Pierre Fabre Announce Manufacturing Agreement For ANX-188 Drug ... MarketWatch (press release) For 10 years, Pierre Fabre has successfully developed highly technical manufacturing processes at its FDA-inspected facilities in Pau and Gaillac as a contract manufacturer for international pharmaceutical companies. "We are delighted that the two ... See all stories on this topic » | ||
| Foamtec Introduces Sahara Corrosion Cleaning System(SM) MarketWatch (press release) OCEANSIDE, CA, Jun 12, 2012 (MARKETWIRE via COMTEX) -- As Pharmaceutical and Biotech companies struggle to maintain their facilities in audit-ready conditions to comply with cGMP guidelines, one company has introduced a safe, environmentally friendly ... See all stories on this topic » | ||
| Stellar Pharmaceuticals to Present at the Bloom Burton Investor Conference June 21 Healthcare Global (press release) LONDON, ONTARIO--(Marketwire - June 11, 2012) - Stellar Pharmaceuticals Inc. ("Stellar" or "the Company") (OTCQB:SLXCF)(OTCBB:SLXCF)(PINKSHEETS:SLXCF), an emerging Canadian specialty pharmaceutical company focused on the acquisition, licensing, ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment